Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 1-18
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.1
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.1
Target | Inducer | Function | Ref. |
System Xc- | Erastin | Inhibits the activity of System Xc- and affects the synthesis of GSH; binds to VDAC2/3 to induce mitochondrial dysfunction | [3,6] |
Erastin analogs, piperazine erastin, imidazole ketone erastin | Inhibits the activity of System Xc- and affects the synthesis of GSH | [103,104] | |
Sulfasalazine | Inhibits the activity of System Xc- (weaker inhibitory effect than erastin) | [3,105,106] | |
Sorafenib | Inhibits the activity of System Xc- (directly affects the synthesis of GSH in a narrow concentration range) | [107] | |
Glutamate | Inhibits the activity of System Xc-, high extracellular glutamate concentrations prevent cystine import | [3,7] | |
GPX4 | (1S,3R)-RSL3 | Covalently binds to the selenocysteine residue of GPX4 | [5,26] |
DPI7 (ML162), DPI12, DPI17 | Covalently bind to GPX4 (at the same binding site as RSL3) | [7,26] | |
DPI10 (ML120), DPI13 | Indirectly inhibit GPX4 activity or bind to a site different from RSL3 | [26,103] | |
FIN56 | Induces GPX4 degradation; binds and activates SQS to deplete CoQ10 | [108] | |
Altretamine | Inhibits the activity of GPX4 | [64] | |
GSH | BSO | GSH depletion | [7,103] |
Cisplatin | Binds to GSH to inactivate GXP4 | [109] | |
DPI2 | Depletes GSH | [7,103] | |
Cysteinase | Depletes cysteine, resulting in GSH depletion | [7] | |
Piperlongumine | Depletes GSH and inhibits the activity of GXP4 | [7,64] | |
ROS and iron | FINO2 | Oxidizes Fe2+ ions and promotes intracellular accumulation of ROS; indirectly inactivates GPX4; directly oxidizes PUFAs | [110] |
Ferric ammonium citrate | Increases iron abundance | [7] | |
Silica-based nanoparticles | Delivers iron into cells and reduce GSH abundance | [7] | |
Heme | Upregulates HMOX1 expression and increases the intracellular level of labile iron | [111] | |
ART, DHA | Oxidize Fe2+ ions and promote intracellular accumulation of ROS; induce ferritinophagy and the release of labile iron | [7,51,65] | |
Siramesine and lapatinib | Downregulate FPN expression and upregulate TRF expression to increase intracellular labile iron levels | [112] |
- Citation: Yang F, Sun SY, Wang S, Guo JT, Liu X, Ge N, Wang GX. Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates. World J Gastrointest Oncol 2022; 14(1): 1-18
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/1.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.1